Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations
- PMID: 30793097
- PMCID: PMC6376509
- DOI: 10.1177/2515135519826481
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations
Abstract
Vaccination is the most practical means available for preventing influenza. Influenza vaccines require frequent updates to keep pace with antigenic drift of the virus, and the effectiveness, and sometimes the safety, of the vaccine can therefore vary from season to season. Three key populations that the World Health Organization recommends should be prioritized for influenza vaccination are pregnant women, children younger than 5 years of age and the elderly. This review discusses the burden of influenza and the safety and effectiveness profile of influenza vaccines recommended for these groups.
Keywords: aged; child; effectiveness; efficacy; immunogenicity; influenza; pregnancy; reactogenicity; safety; vaccination.
Conflict of interest statement
Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.
References
-
- Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 2011; 29: 7554–7558. - PubMed
-
- Savidan E, Chevat C, Marsh G. Economic evidence of influenza vaccination in children. Health Policy 2008; 86: 142–152. - PubMed
-
- Barr IG, McCauley J, Cox N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season. Vaccine 2009; 28: 1156–1167. - PubMed
-
- Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet 2009; 375: 6–9. - PubMed
-
- Last J, Porta M. A dictionary of epidemiology. 5th ed. New York: Oxford University Press, 2008.
